A mathematical computer simulation model for the development of colonic polyps and colon cancer
- 1 August 1991
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 47 (4) , 243-252
- https://doi.org/10.1002/jso.2930470409
Abstract
Currently known information about the development and progression of colon polyps and cancer is summarized and organized into a mathematical computer simulation model that successfully predicts the natural history of colon polyp and cancer development for an average patient with (1) familial polyposis coli (2) genetic susceptibility as measured by a positive family history, and (3) negative family history with a high fat diet. The mathematical model uses four distinct types of cells (normal, transformed, polypoid, and cancerous) and two kinetic processes (mutation and promotion). Arachidonic acid metabolites play a role in the model in the promotion of cancer from polyps, and account for that promotion through: (1) their effect on encouraging more polypoid cells in mitosis to move toward cancer; and (2) their immunosuppressive effect over time. The model also shows that one defect in allowing more cells to mutate to the transformed state is sufficient to account for the chain of events leading to the clinical sequelae of familial polyposis coli. A second genetic effect at another point in the process is unnecessary. The mechanism of action of Sulindac on colon polyps is explained by the model through inhibition of production of arachidonic acid metabolites, most notably prostaglandin E.Keywords
This publication has 33 references indexed in Scilit:
- Genetic Analysis of an Inherited Predisposition to Colon Cancer in a Family with a Variable Number of Adenomatous PolypsNew England Journal of Medicine, 1990
- Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion and ornithine decarboxylase activity by quercetin: possible involvement of lipoxygenase inhibitionCarcinogenesis: Integrative Cancer Research, 1983
- Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced epidermal ornithine decarboxylase activity by lipoxygenase inhibitors: possible role of product(s) of lipoxygenase pathwayCarcinogenesis: Integrative Cancer Research, 1982
- Indomethacin enhancement of TPA tumor promotion in mice☆Cancer Letters, 1980
- Indomethacin inhibition of cell proliferation induced by the phorbolester TPA is reversed by prostaglandin E2 in mouse epidermis in vivoBiochemical and Biophysical Research Communications, 1978
- Enhancement of natural and antibody-dependent lymphocyte cytotoxicity by drugs which inhibit prostaglandin production by tumor target cellsCellular Immunology, 1978
- Prostaglandins and skin tumor promotion: Inhibition of tumor promoter-induced ornithine decarboxylase activity in epidermis by inhibitors of prostaglandin synthesisBiochemical and Biophysical Research Communications, 1977
- PROSTAGLANDINS AND BREAST CANCERThe Lancet, 1977
- Fluocinolone acetonide: A potent inhibitor of mouse skin tumor promotion and epidermal DNA synthesisChemico-Biological Interactions, 1977
- Prostaglandin production by mouse fibrosarcoma cells in culture: Inhibition by indomethacin and aspirinBiochemical and Biophysical Research Communications, 1972